IPR2016-01580

AMNEAL PHARMACUTICALS LLC, (Petitioner)
v.
HOSPIRA INC. (Patent Owner)

February 3, 2017

Illustrative Claim of U.S. Patent 8,648,106 B2:

1.    A ready to use liquid pharmaceutical composition for parenteral administration to a subject, comprising dexmedetomidine or a pharmaceutically acceptable salt thereof disposed within a sealed glass container, wherein the liquid pharmaceutical composition when stored in the glass container for at least five months exhibits no more than about 2% decrease in the concentration of dexmedetomidine.